Cleared Traditional

K915698 - FIBRINOSTIKA TDP MICROELISA SYSTEM

K915698 is an FDA 510(k) clearance for FIBRINOSTIKA TDP MICROELISA SYSTEM, manufactured by Organon Teknika Corp.. The device is a Class 2 Hematology device with product code DAP cleared through the Traditional 510(k) pathway after a 226-day FDA review.

K915698 · Organon Teknika Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1992
Decision
226d
Days
Class 2
Risk

K915698 is an FDA 510(k) clearance for the FIBRINOSTIKA TDP MICROELISA SYSTEM. Classified as Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (product code DAP), Class II - Special Controls.

Submitted by Organon Teknika Corp. (Durham, US). The FDA issued a Cleared decision on August 5, 1992 after a review of 226 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Organon Teknika Corp. devices

FDA 510(k) Submission Details - K915698

510(k) Number K915698 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 1991
Decision Date August 05, 1992
Days to Decision 226 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
113d slower than avg
Panel avg: 113d · This submission: 226d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DAP Device Classification - Class 2, Special Controls

Product Code DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 44
Devices cleared under the same product code (DAP) and FDA review panel - the closest regulatory comparables to K915698.
STA-LIATEST D-DI TEST KIT
K964728 · American Bioproducts Co. · Jun 1997
STA D-DI CALIBRATOR KIT
K964718 · American Bioproducts Co. · May 1997
AURATEK FDP
K943787 · Organon Teknika Corp. · Sep 1994
FDP PLASMA TEST KIT
K920943 · American Bioproducts Co. · Jul 1992
D-DIMER WELLCOTEST (HA10)
K915203 · Wellcome Diagnostics · Jan 1992
FIBRINOSTIKA FBDP MICROELISA SYSTEM
K912876 · Organon Teknika Corp. · Oct 1991